Categories: NewsPharmaceutical

Ultragenyx to Present at the 2023 Barclays – Gene Editing & Gene Therapy Summit

NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company’s chief medical officer, will present at the 2023 Barclays – Gene Editing & Gene Therapy Summit on Wednesday, May 24, 2023, at 8:50 a.m. ET.

The live and archived webcast of the panel will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations.

About Ultragenyx Pharmaceutical Inc.

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company’s website at: www.ultragenyx.com.

Contacts – Ultragenyx Pharmaceutical, Inc.
Investors
Joshua Higa
ir@ultragenyx.com

Media
Jeff Blake
media@ultragenyx.com

Staff

Recent Posts

Digital Case Acceptance Platform Reports Record Data for Case Acceptance and Productivity After Months of Testing

AcceptCare Adds New Tool to Increase High-Value Treatments like Ortho DENVER, CO / ACCESSWIRE /…

3 hours ago

AscellaHealth Chairman and President Bill Oldham Named 2024 Philadelphia Titan 100

BERWYN, Pa.--(BUSINESS WIRE)--Titan CEO and headline sponsor Wipfli LLP are pleased to announce Bill Oldham, chairman…

6 hours ago

24-Provider Rockbridge Area Health Center Enhances Clinical Efficiency Using Sunoh.ai

The FQHC leverages eClinicalWorks EDR and AI-powered medical scribe to reduce physician burnout and improve…

6 hours ago

Osteotec announces strategic collaboration with Additive Surgical, bringing cutting-edge 3D-printed spine technology to the UK

NEWBURY, England, June 13, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical…

6 hours ago

ImpediMed Appoints Google Financial Executive Fiona Bones to Board of Directors

Google executive brings more than two decades of financial and management expertise to medical technology…

6 hours ago

EPAM Acquires Odysseus — to transform the Life Sciences Value Chain with Advanced Analytics, Data Methods and AI

Improving life sciences research, clinical studies and post-market surveillance powered by data and AI NEWTOWN,…

6 hours ago